Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid TumorsRecruiting
NCT07660055Phase 1Updated Jul 28, 2026
Sponsor: Novartis Pharmaceuticals
Breast Cancer · Non-small Cell Lung Cancer (NSCLC) · Gastric/Gastroesophageal Junction (GEJ) Cancer · Bladder Cancer
United States, Australia, Canada, Japan
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and InflammationCompleted
NCT05021835Phase 3Updated Jul 28, 2026
Sponsor: Novo Nordisk A/S
Cardiovascular Risk · Chronic Kidney Disease · Inflammation
United States, Argentina, Australia, Belgium, Brazil +33 more
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia AActive Not Recruiting
NCT04644575Phase 3Updated Jul 28, 2026
Sponsor: Bioverativ, a Sanofi company
Hemophilia A
United States, Argentina, Australia, Belgium, Brazil +18 more
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic AlterationsActive Not Recruiting
NCT06644768Phase 1, Phase 2Updated Jul 28, 2026
Sponsor: Daiichi Sankyo
Non-small Cell Lung Cancer · Lung Cancer
United States, Argentina, Brazil, China, Japan
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.Recruiting
NCT04752774Phase 1, Phase 2Updated Jul 28, 2026
Sponsor: Ipsen
Spasticity
United States, Austria, Bulgaria, Czechia, France +9 more
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in AdultsRecruiting
NCT06625060Phase 2Updated Jul 28, 2026
Sponsor: Ipsen
Episodic Migraine · Chronic Migraine
United States, Australia, Brazil, Canada, Czechia +9 more
A Study to Test Whether Different Doses of BI 1291583 Help People With BronchiectasisCompleted
NCT05238675Phase 2Updated Jul 28, 2026
Sponsor: Boehringer Ingelheim
Bronchiectasis
United States, Australia, Belgium, Bulgaria, Canada +18 more
Study of DS-1001b in Patients With Gene IDH1-Mutated GliomasCompleted
NCT03030066Phase 1Updated Jul 28, 2026
Sponsor: Daiichi Sankyo
Glioma
Japan
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRecruiting
NCT06742723Phase 3Updated Jul 28, 2026
Sponsor: AstraZeneca
Chronic Kidney Disease and Hypertension
United States, Argentina, Australia, Belgium, Brazil +37 more
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard TreatmentRecruiting
NCT07036523Phase 2Updated Jul 28, 2026
Sponsor: Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
United States, Australia, Belgium, Canada, Germany +5 more
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or RearrangementRecruiting
NCT05727176Phase 2Updated Jul 28, 2026
Sponsor: Taiho Oncology, Inc.
Advanced Cholangiocarcinoma · FGFR2 Fusions · Gene Rearrangement
United States, Argentina, Australia, Brazil, Canada +8 more
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT04928846Phase 3Updated Jul 28, 2026
Sponsor: AbbVie
Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +27 more
Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving OpioidsRecruiting
NCT05588323Phase 1, Phase 2Updated Jul 28, 2026
Sponsor: Shionogi
Opioid-Induced Constipation (OIC)
Albania, Armenia, Belgium, Bosnia and Herzegovina, France +3 more
A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.Active Not Recruiting
NCT05984277Phase 3Updated Jul 28, 2026
Sponsor: AstraZeneca
Metastatic Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +20 more
A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a Blood Clotting Disorder Called Thrombotic Microangiopathy (TMA) After Undergoing a Hematopoietic Stem Cell Transplant (HSCT).Completed
NCT07732361N/AUpdated Jul 28, 2026
Sponsor: Alexion Pharmaceuticals, Inc.
Thrombotic Microangiopathy · Hematopoietic Stem Cell Transplant
United States, Belgium, Brazil, France, Greece +5 more
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)Recruiting
NCT05454787N/AUpdated Jul 28, 2026
Sponsor: AstraZeneca
Life Threatening Bleeding · Factor Xa Inhibitor
Japan
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerRecruiting
NCT06161025Phase 2, Phase 3Updated Jul 28, 2026
Sponsor: Daiichi Sankyo
Solid Cancer
United States, Australia, Brazil, Canada, China +14 more
Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate CancerActive Not Recruiting
NCT06441994Phase 1Updated Jul 28, 2026
Sponsor: Osaka University
Prostate Cancer
Japan
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement InhibitorsActive Not Recruiting
NCT04432584Phase 3Updated Jul 28, 2026
Sponsor: Hoffmann-La Roche
Paroxysmal Nocturnal Hemoglobinuria
United States, Belgium, Brazil, Czechia, Estonia +19 more
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus ErythematosusActive Not Recruiting
NCT05648500Phase 3Updated Jul 28, 2026
Sponsor: Viatris Innovation GmbH
Lupus Erythematosus, Systemic
United States, Argentina, Brazil, Bulgaria, Colombia +12 more
Study of PIT565 in Relapsed and/or Refractory B-cell MalignanciesActive Not Recruiting
NCT05397496Phase 1Updated Jul 28, 2026
Sponsor: Novartis Pharmaceuticals
B-cell Non-Hodgkin Lymphoma (B-NHL) · B-cell Acute Lymphoblastic Leukemia (B-ALL)
United States, Belgium, China, France, Israel +4 more
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural MesotheliomaActive Not Recruiting
NCT06097728Phase 3Updated Jul 28, 2026
Sponsor: AstraZeneca
Unresectable Pleural Mesothelioma
United States, Australia, Belgium, Brazil, Canada +16 more
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)Recruiting
NCT06979336Phase 2Updated Jul 28, 2026
Sponsor: Genentech, Inc.
Ulcerative Colitis
United States, Australia, Brazil, Canada, China +10 more
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial CancerRecruiting
NCT07022483Phase 3Updated Jul 28, 2026
Sponsor: Daiichi Sankyo
Endometrial Cancer
United States, Argentina, Chile, China, France +8 more
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHDRecruiting
NCT07038200Phase 3Updated Jul 27, 2026
Sponsor: Avidity Biosciences, Inc.
Facioscapulohumeral Muscular Dystrophy · FSHD · FSHD - Facioscapulohumeral Muscular Dystrophy · FSHD1
United States, Canada, Denmark, France, Germany +5 more

Previous page Next page